Antiperspirant in the Treatment of Residual Limp Hyperhidrosis for Prosthetic Users

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

August 9, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

March 30, 2023

Conditions
HyperhidrosisResidual Limbs
Interventions
OTHER

Topical antiperspirant

The participants will be instructed to use topical antiperspirant (aluminum chloride, 15 percent every evening for four weeks. The PI will contact the participants every week. If the participant experiences that antiperspirant have an effect, the use of antiperspirant will be reduced from daily use to 3 times a week.

Trial Locations (1)

0667

Sophies Minde Ortopdi AS, Oslo

All Listed Sponsors
lead

Sophies Minde Ortopedi

INDUSTRY